Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDFSD Pharma Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2024 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2024 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q1 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q2 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
FSD Pharma Inc. Earnings Date And Information
FSD Pharma Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.08 earnings per share for the quarter, missing analysts' consensus estimates of $-0.06 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. FSD Pharma Inc. has generated $0 earnings per share over the last year ($-0.47 diluted earnings per share) and currently has a price-to-earnings ratio of -0.27. FSD Pharma Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
FSD Pharma Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/29/2024 | Q1 2024 | -$0.05 | $714,692 | $0 | ||
| 04/01/2024 | Q4 2023 | -$0.04 | $0 | |||
| 09/29/2023 | Q3 2023 | -$0.03 | $0 | |||
| 06/30/2023 | Q2 2023 | -$0.21 | $0 | |||
| 03/31/2023 | Q1 2023 | -$0.28 | $0 | |||
| 03/31/2023 | Q4 2022 | -$0.15 | $0 | |||
| 09/12/2022 | Q3 2022 | -$0.19 | $0 | |||
| 06/30/2022 | Q2 2022 | -$0.12 | $0 | |||
| 03/31/2022 | Q1 2022 | -$0.14 | $0 | |||
| 03/31/2022 | Q4 2021 | -$0.18 | $0 | |||
| 11/12/2021 | Q3 2021 | -$0.16 | $0 | |||
| 08/12/2021 | Q2 2021 | -$0.37 | $0 | |||
| 08/12/2021 | Q1 2021 | -$0.37 | $0 | |||
| 11/16/2020 | Q4 2020 | -$0.36 | $0 | |||
| 08/10/2020 | Q3 2020 | -$1.06 | $0 | |||
| 05/15/2020 | Q2 2020 | -$0.48 | $8,366 | |||
| 05/15/2020 | Q1 2020 | -$1.08 | $0 | |||
| 12/31/2019 | Q4 2019 | -$2.19 | $210,375 | $159,195 | ||
| 09/30/2019 | Q3 2019 | -$1.66 | $302,586 | $9,673 | ||
| 06/30/2019 | Q2 2019 | -$1.55 | $14,092 |
FSD Pharma Inc. Earnings: FAQ's
When is FSD Pharma Inc.'s earnings date?
FSD Pharma Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
How can I listen to FSD Pharma Inc.'s earnings conference
call?
The conference call for FSD Pharma Inc.'s latest earnings report can be listened to online.
How can I read FSD Pharma Inc.'s conference call transcript?
The conference call transcript for FSD Pharma Inc.'s latest earnings report can be read online.
How much profit does FSD Pharma Inc. generate each year?
FSD Pharma Inc. (:HUGE) has a recorded net income of $0. FSD Pharma Inc. has generated $-0.47 earnings per share over the last four quarters.
What is FSD Pharma Inc.'s price-to-earnings ratio?
FSD Pharma Inc. (:HUGE) has a price-to-earnings ratio of -0.27 and price/earnings-to-growth ratio is -0.01.